965 related articles for article (PubMed ID: 17213041)
1. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
2. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
3. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
4. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
5. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
6. [Changes of matrix metalloproteinases activities in pulmonary fibrosis rats].
Kong L; Pan Y; Yu HF; Wang JF; Niu JZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):717-20. PubMed ID: 17121240
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats.
Liu R; Ahmed KM; Nantajit D; Rosenthal FS; Hai CX; Li JJ
Int J Mol Med; 2007 Jun; 19(6):865-73. PubMed ID: 17487418
[TBL] [Abstract][Full Text] [Related]
10. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
Zhang XF; Zhu GF; Liu S; Foda HD
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070
[TBL] [Abstract][Full Text] [Related]
11. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis.
Kim JY; Choeng HC; Ahn C; Cho SH
Yonsei Med J; 2009 Feb; 50(1):68-77. PubMed ID: 19259351
[TBL] [Abstract][Full Text] [Related]
12. Unbalanced MMP/TIMP-1 expression during the development of experimental pulmonary fibrosis with acute paraquat poisoning.
Wang BL; Tu YY; Fu JF; Zhong YX; Fu GQ; Tian XX; Wang LH; Gong L; Ren QY
Mol Med Rep; 2011; 4(2):243-8. PubMed ID: 21468558
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.
Madtes DK; Elston AL; Kaback LA; Clark JG
Am J Respir Cell Mol Biol; 2001 May; 24(5):599-607. PubMed ID: 11350830
[TBL] [Abstract][Full Text] [Related]
14. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling.
Gao J; Feng LJ; Huang Y; Li P; Xu DJ; Li J; Wu Q
J Pharm Pharmacol; 2012 Jun; 64(6):811-20. PubMed ID: 22571259
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Fuzheng Huayu recipe on MMP-2 activity and type IV collagen expression at fibrotic lung].
Tan SZ; Liu CH; Zhang W; Lu X; Ye WC; Cai ZZ; Liu P
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):835-9. PubMed ID: 17639988
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase -2, -9 and tissue inhibitors of metalloproteinase -1, -2, -3 mRNAs in rat uterus during early pregnancy.
Zhao YG; Xiao AZ; Cao XM; Zhu C
Mol Reprod Dev; 2002 Jun; 62(2):149-58. PubMed ID: 11984824
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
20. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
